SABA prescribing and social deprivation: OPC and OPRI at the ERS Congress (2 of 4)

The second paper presented by OPC at the European Respiratory Society Congress 2024 is below. This paper utilised data from the OPC Research Database with analysis supported by OPRI. ?The of our ERS summary articles can found here and the other two papers will be uploaded this week.

? ?

Excess SABA prescribing in respiratory patients and social deprivation in general practice: A study of 4 million patients?

Authors: Michael Crooks, Heath Heatley , Katherine Hickman , Joan B Soriano, M.D., Ph.D., FERS,FCCP , and David Price .

Focus: This study explored how social deprivation is related to the over-prescription of short-acting β2-agonists (SABA) in patients with respiratory diseases. Excessive SABA prescribing is often a sign of poor disease control.

Key Insights: Analysing data from over 4 million patients, the study found a distinct connection between socioeconomic deprivation and excessive SABA prescriptions. ?The work also highlighted that nearly half (47%) of patients that receive a SABA prescription do not have an Asthma or COPD diagnosis, with this accounting for 12% of all SABA prescriptions.

The Optimum Patient Care Research Database (OPCRD) provides de-identified data from over 1,100 general practices across the UK and over 24 million de-identified patients. For more information click here.

OPRI, the Observational & Pragmatic Research Institute, is an independent research organisation distinguished in accessing unique global data sources to deliver observational and pragmatic research. For more information click here.